QuidelOrtho
its InflammaDry test detects elevated MMP-9, an inflammatory marker associated with dry eye disease, though a 2026 industry report flagged a supply disruption affecting at least one distribution channel for the product.
- Country
- United States
- Ticker
- QDEL
Commercial
InflammaDry MMP-9 test
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Tear-fluid biopsy | diagnostics-medtech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.